Skip to main content

US ClosedU.S. Closed

ALXO: ALX Oncology Holdings Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

ALX Oncology Holdings Inc. , a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

52W Range

61stpctl

Volume

0.52×avg

Market Cap

269.13MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

ALX Oncology Holdings Inc.

ALXONASDAQ·USD·Closed

ALX Oncology Holdings Inc.

ALXONASDAQ·USD·Closed

$2.00

−2.44%

$2.00

−$0.05 (2.44%)

52W Range

61stpctl

Volume

0.52×avg

Mkt Cap

269.13MUSD

P/E

-1.8TTM

Div Yield

–ann